13F HOLDINGS REPORT
MPM ASSET MANAGEMENT LLC
Quarter ended Q4 2024 · Filed February 14, 2025 · Accession 0000950123-25-002793
Total Value
$124.4M
Positions
6
Other Managers
0
Confidential Omitted
No
Holdings (6)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Entrada Therapeutics, Inc. | TRDA | 4,381,062 | $75.7M | 60.89% |
| 2 | iTeos Therapeutics, Inc. | 46565G104 | 2,738,785 | $21.0M | 16.91% |
| 3 | Dyne Therapeutics, Inc. | DYN | 682,376 | $16.1M | 12.92% |
| 4 | Werewolf Therapeutics, Inc. | HOWL | 4,284,172 | $6.3M | 5.10% |
| 5 | Adaptimmune Therapeutics plc | ADTI | 5,555,461 | $3.0M | 2.41% |
| 6 | Repare Therapeutics, Inc. | 760273102 | 1,683,707 | $2.2M | 1.77% |